Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Merus N.V. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 179 | 2 | 189 | +12 |
| Shares | 66.5M | 1.58M | 69.0M | +4.10M (+6.3%) |
| Value | $3.94B | $93.6M | $3.45B | −$388.5M (−10.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Merus N.V. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (19)
Institutions that held Merus N.V. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BVF Inc | 1,279,049 | $75.7M |
| Artal Group S.A. | 760,355 | $45.0M |
| OrbiMed Advisors LLC | 156,100 | $9.24M |
| Integral Health Asset Management, LLC | 100,000 | $5.92M |
| BCJ Capital Management, LLC | 54,957 | $3.25M |
| Exome Asset Management LLC | 45,100 | $2.67M |
| Atom Investors LP | 43,827 | $2.59M |
| Tudor Investment Corp Et Al | 42,359 | $2.51M |
| Carmignac Gestion | 42,278 | $2.50M |
| Entropy Technologies, LP | 12,847 | $760.2K |
| Prelude Capital Management, LLC | 9,400 | $556.2K |
| Mirabella Financial Services LLP | 5,289 | $312.9K |
| Farallon Capital Management, L.L.C. | 4,000 | $236.7K |
| LMR Partners LLP | 4,000 | $236.7K |
| Mariner, LLC | 3,718 | $220.5K |
| IFP Advisors, Inc | 750 | $44.4K |
| Hollencrest Capital Management | 90 | $5.33K |
| Mather Group, LLC. | 100 | $4.50K |
| Twin Tree Management, LP | 6 | $355 |
Not filed for Q3 2024 yet (2)
Institutions that held Merus N.V. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,525,749 | $90.3M |
| Susquehanna Fundamental Investments, LLC | 56,778 | $3.36M |